Could The Market Be Wrong About Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Its Attractive Financial Prospects?

Catalyst Pharmaceuticals (NASDAQ:CPRX) has had a rough month with its share price down 8.7%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals us

Simply Wall StJun 17 10:59 ET

Catalyst Pharmaceuticals(CPRX.US) Officer Sells US$121.18K in Common Stock

$Catalyst Pharmaceuticals(CPRX.US)$ Officer Del Carmen Jeffrey sold 7,541 shares of common stock on Jun 7, 2024 at an average price of $16.07 for a total value of $121.18K.Source: Announcement What is

moomoo NewsJun 11 17:43 ET

Form 144 | Catalyst Pharmaceuticals(CPRX.US) Officer Proposes to Sell 121.18K in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 7, $Catalyst Pharmaceuticals(CPRX.US)$ Officer Del Carmen Jeffrey intends to sell 7,541 shares of its common stock on Jun 7, with a total market value of approximately $121

moomoo NewsJun 7 11:22 ET

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong Financials Guiding The Market?

Yahoo FinanceJun 7 11:16 ET

Oppenheimer Maintains Catalyst Pharmaceuticals(CPRX.US) With Buy Rating, Maintains Target Price $29

Oppenheimer analyst Leland Gershell maintains $Catalyst Pharmaceuticals(CPRX.US)$ with a buy rating, and maintains the target price at $29.According to TipRanks data, the analyst has a success rate of

moomoo NewsJun 6 08:31 ET

Catalyst Pharmaceuticals(CPRX.US) Director Sells US$86,949.23 in Common Stock

$Catalyst Pharmaceuticals(CPRX.US)$ Director Harper Molly sold 5,333 shares of common stock on Jun 3, 2024 at an average price of $16.304 for a total value of $86,949.23.Source: Announcement What is s

moomoo NewsJun 5 17:40 ET